TP53 and melanoma: To investigate the impact of constitutive IER2 expression in melanoma, we generated IER2-inducible RheoSwitch B16–F10 (B16) and Ret mouse melanoma cells, which both harbor wild-type p53 (p53WT) and express only very low levels of IER2.